Soleno Therapeutics (SLNO) Other Non Operating Income (2013 - 2023)
Soleno Therapeutics (SLNO) reported Other Non Operating Income of $2.1 million for Q4 2023, up 1615.2% year-over-year from $125000.0 in Q4 2022, and up 1132.18% on a QoQ basis from $174000.0 in Q3 2023.
Soleno Therapeutics (SLNO) has 11 years of Other Non Operating Income data on file, last reported at $2.1 million in Q4 2023.
- Quarterly Other Non Operating Income rose 1615.2% year-over-year to $2.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $2.6 million (up 759.33% YoY) and the FY2023 annual result came in at $2.6 million, up 759.33% from the prior year.
- Other Non Operating Income rose to $2.1 million in Q4 2023 per SLNO's latest filing, from $174000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $2.1 million in Q4 2023 and bottomed at $1000.0 in Q2 2020.
- The 5-year median for Other Non Operating Income is $41000.0 (2021), against an average of $166052.6.
- The widest annual swing landed in 2020, when Other Non Operating Income slumped 97.87%; it then surged 4000.0% in 2021.
- Tracing SLNO's Other Non Operating Income over 5 years: stood at $21000.0 in 2019, then tumbled by 95.24% to $1000.0 in 2020, then soared by 3300.0% to $34000.0 in 2021, then soared by 267.65% to $125000.0 in 2022, then surged by 1615.2% to $2.1 million in 2023.
- Per Business Quant, the three latest SLNO Other Non Operating Income figures stand at $2.1 million (Q4 2023), $174000.0 (Q3 2023), and $147000.0 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 174,000.00 |
| Jun 30, 2023 | 147,000.00 |
| Mar 31, 2023 | 113,000.00 |
| Dec 31, 2022 | 125,000.00 |
| Sep 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 52,000.00 |
| Mar 31, 2022 | 22,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 34,000.00 |
| Jun 30, 2021 | 41,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 11,000.00 |
| Dec 31, 2019 | 21,000.00 |
| Sep 30, 2019 | 29,000.00 |
| Jun 30, 2019 | 47,000.00 |
| Mar 31, 2019 | 57,000.00 |
| Dec 31, 2018 | 29,000.00 |
| Sep 30, 2018 | 26,000.00 |
| Jun 30, 2018 | 30,000.00 |
| Mar 31, 2018 | 19,000.00 |
| Dec 31, 2017 | 5,000.00 |
| Sep 30, 2017 | 3,000.00 |
| Jun 30, 2017 | -88,000.00 |
| Mar 31, 2017 | -672,000.00 |
| Dec 31, 2016 | 411,497.00 |
| Sep 30, 2016 | 191,000.00 |
| Jun 30, 2016 | -72,000.00 |
| Mar 31, 2016 | 1.07 Mn |
| Dec 31, 2015 | 662,200.00 |
| Sep 30, 2015 | -110,000.00 |
| Jun 30, 2015 | 4.93 Mn |
| Mar 31, 2015 | -9.23 Mn |
| Dec 31, 2014 | -1.24 Mn |
| Sep 30, 2014 | -1.07 Mn |
| Jun 30, 2014 | -1.49 Mn |
| Mar 31, 2014 | -8,000.00 |
| Dec 31, 2013 | -104,965.00 |
| Sep 30, 2013 | -26,000.00 |